Break free
Help your equine patients
by controlling the clinical signs
associated with osteoarthritis
• The only FDA approved pentosan polysulfate sodium injection
• Convenient; only 4 intramuscular injections required
• Not limited to use for specific joints
1
1. Zycosan® Freedom of Information Summary NADA 141-559
© 2023 Dechra Veterinary Products. Dechra is a registered trademark of Dechra Pharmaceuticals PLC. Zycosan is a registered trademark of Dechra Limited; all rights reserved. E230047
To learn more about Zycosan
®
, please scan the QR code or
visit go.dechra-us.com/zycosan
24-hour Veterinary Technical Support available: (866) 933-2472
Nonurgent Technical Support available: support@dechra.com
Important Satefy Information
As with all drugs, side effects may occur. For intramuscular use in horses only. Not for use in humans. Pentosan polysulfate sodium is
a weak anticoagulant. Caution should be used when administering Zycosan if you are taking an anticoagulant. In case of accidental
self-injection, seek immediate medical attention. If product comes into contact with skin, rinse skin thoroughly with water and seek
medical attention if needed. Horses with hypersensitivity to pentosan polysulfate sodium should not receive Zycosan. Do not use Zycosan
concurrently with other anticoagulant drugs. Do not use in horses with clotting disorders or within 24 hours of surgical procedures. Caution
should be used when administering this drug before or after strenuous activities. Caution should be used when NSAIDS are administered
concurrently due to the anticoagulant effects of Zycosan. If Zycosan and NSAIDS are used concurrently, horses should be monitored for
hemorrhage or other clinical signs of abnormal bleeding. The safe use of Zycosan has not been evaluated in breeding, pregnant, or lactating
horses. The safety of long-term repeat use of Zycosan has not been evaluated. The most frequently reported adverse reactions are injection
site reactions, prolongation of coagulation parameters (activated partial thromboplastin time (aPTT) and prothrombin time (PT). Refer to the
prescribing information for complete details or visit www.dechra-us.com.
